{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:03Z","timestamp":1753891983449,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>A 58-year-old male was admitted to our hospital due to lasting fever, progressive lymphadenopathy and bicytopenia, with a previously histological diagnosis of follicular lymphoma grade 3a with Epstein\u2013Barr virus-encoded RNA positive one month ago. A second biopsy of axillary lymph node revealed concurrent diffuse large B-cell lymphoma with Epstein\u2013Barr virus-encoded RNA positive. Another diagnosis of hemophagocytic lymphohistiocytosis secondary to Epstein\u2013Barr virus positive diffuse large B-cell lymphoma was further concluded by clinical manifestation, laboratory test and atypical lymphocytes in peripheral-blood smear. After a pulse of steroid pre-phase treatment, the patient\u2019s clinical condition deteriorated and died in two weeks. The presence of Epstein\u2013Barr virus infection in patients with follicular lymphoma is associated with more aggressive clinical course and increased risk of high-grade transformation. Hemophagocytic lymphohistiocytosis in response to Epstein\u2013Barr virus infection or lymphoma remains fatal. Early diagnosis and initiation of treatment may improve the outcome.<\/jats:p>","DOI":"10.3389\/fonc.2021.681432","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T05:18:47Z","timestamp":1624598327000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Secondary Hemophagocytic Lymphohistiocytosis With Epstein\u2013Barr Virus-Associated Transformed Follicular Lymphoma: A Case Report and Literature Review"],"prefix":"10.3389","volume":"11","author":[{"given":"Huan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.014.10208","article-title":"Epstein-Barr Virus at 50-Future Perspectives","volume":"33","author":"Young","year":"2014","journal-title":"Chin J Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203217","article-title":"Epstein-Barr Virus Transformation: Involvement of Latent Membrane Protein 1-Mediated Activation of NF-Kappab","volume":"18","author":"Cahir McFarland","year":"1999","journal-title":"Oncogene"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.214","article-title":"Epstein-Barr Virus-Positive Follicular Lymphoma","volume":"30","author":"Mackrides","year":"2017","journal-title":"Mod Pathol"},{"key":"B4","article-title":"The Ambiguous Boundary Between EBV-related Hemophagocytic Lymphohistiocytosis and Systemic EBV-Driven T Cell Lymphoproliferative Disorder","volume":"7","author":"Smith","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/1066896909341803","article-title":"Synchronous Follicular Lymphoma, Kaposi Sarcoma, and Castleman\u2019s Disease in a HIV-negative Patient With EBV and HHV-8 Coinfection","volume":"19","author":"Koreishi","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.2377","article-title":"Transformation of Follicular Lymphoma to Epstein-Barr Virus-Related Hodgkin-like Lymphoma","volume":"31","author":"Menon","year":"2013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02579.x","article-title":"Epstein-Barr Virus-Positive Aggressive Lymphoma as a Consequence of Immunosuppression After Multiple Salvage Treatments for Follicular Lymphoma","volume":"112","author":"Orlandi","year":"2001","journal-title":"Br J haematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6281","article-title":"Prognostic Impact of Epstein-Barr Virus (EBV)-DNA Copy Number at Diagnosis in Chronic Lymphocytic Leukemia","volume":"7","author":"Liang","year":"2016","journal-title":"Oncotarget"},{"key":"B9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<99::AID-AJH3>3.0.CO;2-T","article-title":"Epstein-Barr Virus Infection in Richter\u2019s Transformation","volume":"60","author":"Ansell","year":"1999","journal-title":"Am J Hematol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500398856","article-title":"Epstein-Barr Virus in Patients With Chronic Lymphocytic Leukemia: A Pilot Study","volume":"47","author":"Tsimberidou","year":"2006","journal-title":"Leukemia lymphoma"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4170","article-title":"Nuclear and Cytoplasmic AID in Extrafollicular and Germinal Center B Cells","volume":"107","author":"Cattoretti","year":"2006","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610732104","article-title":"Activation-Induced Cytidine Deaminase (AID) Promotes B Cell Lymphomagenesis in Emu-cmyc Transgenic Mice","volume":"104","author":"Kotani","year":"2007","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.03.018","article-title":"Infection of Human B Cells With Epstein-Barr Virus Results in the Expression of Somatic Hypermutation-Inducing Molecules and in the Accrual of Oncogene Mutations","volume":"44","author":"Epeldegui","year":"2007","journal-title":"Mol Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.769218","article-title":"Epstein-Barr Virus Latent Membrane Protein 1 Increases Genomic Instability Through Egr-1-mediated Up-Regulation of Activation-Induced Cytidine Deaminase in B-cell Lymphoma","volume":"54","author":"Kim","year":"2013","journal-title":"Leukemia lymphoma"},{"key":"B15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/leu.2015.285","article-title":"Ebv-miR-BHRF1-2 Targets PRDM1\/Blimp1: Potential Role in EBV Lymphomagenesis","volume":"30","author":"Ma","year":"2016","journal-title":"Leukemia"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"Hlh-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic Lymphohistiocytosis","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult Haemophagocytic Syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet (London England)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/ajh.21811","article-title":"EBV-Associated Hemophagocytic Syndrome","volume":"86","author":"Liapis","year":"2011","journal-title":"Am J Hematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3324\/haematol.2015.123562","article-title":"Consensus Recommendations for the Diagnosis and Management of Hemophagocytic Lymphohistiocytosis Associated With Malignancies","volume":"100","author":"Lehmberg","year":"2015","journal-title":"Haematologica"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2017.1295176","article-title":"A Clinical Study of 21 Patients With Hemophagocytic Syndrome in 295 Cases Diagnosed With Nasal Type, Extranodal Nature Killer\/T Cell Lymphoma","volume":"18","author":"Li","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03709.x","article-title":"Large B Cell Lymphoma Presenting Initially in Bone Marrow, Liver and Spleen: An Aggressive Entity Associated Frequently With Haemophagocytic Syndrome","volume":"57","author":"Yeh","year":"2010","journal-title":"Histopathology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/10428190009053537","article-title":"Treatment Strategies for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (EBV-HLH)","volume":"39","author":"Imashuku","year":"2000","journal-title":"Leukemia lymphoma"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12386","article-title":"Treatment of Epstein Barr Virus-Induced Haemophagocytic Lymphohistiocytosis With Rituximab-Containing Chemo-Immunotherapeutic Regimens","volume":"162","author":"Chellapandian","year":"2013","journal-title":"Br J haematol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2018.1491093","article-title":"Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adults and Adolescents-a Life-Threatening Disease: Analysis of 133 Cases From a Single Center","volume":"23","author":"Lai","year":"2018","journal-title":"Hematol (Amsterdam Netherlands)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.681432\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T05:18:51Z","timestamp":1624598331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.681432\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":25,"alternative-id":["10.3389\/fonc.2021.681432"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.681432","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"article-number":"681432"}}